A carregar...
A phase I and pharmacokinetic study of novel taxane BMS-188797 and cisplatin in patients with advanced solid tumours
This phase I study investigated the maximum tolerated dose and pharmacokinetics of a 3-weekly administration of BMS-188797, a paclitaxel derivate, at three dose levels (DLs) (80, 110 and 150 mg m(−2) DL), combined with cisplatin (standard dose 75 mg m(−2)). In 16 patients with advanced malignancies...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361071/ https://ncbi.nlm.nih.gov/pubmed/16333310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602886 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|